OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Improving Neoadjuvant and Perioperative Therapy in Resectable NSCLC: Moving Beyond a One-Size-Fits-All Approach

Gabriela Norese: Excited to Join the OncoDaily Editorial Board as Reviews Editor

Emmanuel Macron and Tedros Adhanom Ghebreyesus Call for Safer Digital Spaces for Children

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

CheckMate 214 Updates: Nivolumab Plus Ipilimumab Versus Sunitinib in Advanced RCC

Oncology News, Insights, Stories by OncoDaily

Bruce Chabner
OncoDaily Magazine

Logarithmic Expansion of Bruce Chabner

100 influential survivors
OncoDaily 100

100 Influential Cancer Survivors on Social Media: 2026 Edition

FDA Approves Tregzi, the First Regulatory T-Cell Therapy for Allogeneic HSCT
Immune Oncology

FDA Approves Tregzi, the First Regulatory T-Cell Therapy for Allogeneic HSCT

Registration Open for the World Cancer Congress 2026 – UICC

CAPRI-2 GOIM at ESMO GI 2026: Cetuximab Continuation in Molecularly Selected Metastatic Colorectal Cancer

Catherine Lam is the Incoming SIOP Global Health Network Chair

From Hobby to Movement: How Amol Akhade Turned Social Media Into a Global Oncology Classroom

AI Meets the Brain: Inside Insilico and SK Biopharmaceuticals’ $2.5 Billion Neuroimmune Bet

Olympic Truce and OncoCorridor

What Really Killed Napoleon? The Autopsy Evidence Behind His Gastric Cancer Diagnosis

Voices
Servier Pharmaceuticals

Servier Invites to Explore Precision Medicine and Real-World Evidence in Cholangiocarcinoma at ESMO GI 2026

Fundación Aladina Hosts 1st Scientific and Care Symposium on Pediatric Oncology

Terisa Tamang։ Threads of Hope Supports Cancer Caregivers Through Therapeutic Knitting and Crochet

Nina Niu Sanford: Defining the Role of SBRT in HCC Among Local Treatment Modalities

Registration Now Open for EIOC 2026

Nataliya Kovalchuk: Clinical Case of Image-Guided Brachytherapy in Cervical Cancer

Timothy Rebbeck։ Advancing Genomic Equity Through National Genome Projects in Africa

FDA Approvals
FDA belzutifan plus pembro for RCC

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz (pivekimab sunirine-pvzy), the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

OncoDaily 100
100 influential survivors

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

ESSO Advanced Course on the Treatment of Peritoneal Surface Malignancy

European Society of Surgical Oncology

15 Oct
Peritoneal Surface Malignancy

ESSO Hands-On Course on the Minimally Invasive Management of Peritoneal Surface Malignancies

European Society of Surgical Oncology

15 Sep
Peritoneal Surface Malignancies

ESO-ESSO-ESTRO-ESP Multidisciplinary Course on Oncology for Medical Students

European Society for Radiotherapy and Oncology (ESTRO)

24 Aug
Oncology

ESO Ambassador Event on Neoadjuvant and Post-Neoadjuvant Treatment in Breast Cancer

European School of Oncology (ESO) College

30 Oct
Breast Cancer

Community Oncology Global Congress 2026

OncoDaily

28 Aug
Community Oncology Global Congress 2026

Immune-oncology
Neo-CheckRay Trial: Can Radiotherapy Turn Immune-Cold Breast Cancer Into an Immunotherapy Target?

Neo-CheckRay Trial: Can Radiotherapy Turn Immune-Cold Breast Cancer Into an Immunotherapy Target?

FDA Approves Tregzi, the First Regulatory T-Cell Therapy for Allogeneic HSCT

RECLAIM Trial: Can Radiotherapy Restore Immunotherapy Sensitivity?

PD-L1 Alone Is Not Enough: Why It Fails to Predict Immunotherapy Response in NSCLC

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

FDA Approves Sacituzumab Govitecan Plus Pembrolizumab for First-Line PD-L1–Positive TNBC

New Biomarkers for Immunotherapy Success in Metastatic Kidney Cancer

Gastrointestinal-Oncology
Zoldonrasib at ESMO GI 2026

Zoldonrasib Plus Chemo at ESMO GI 2026: First-Line RAS G12D Metastatic Pancreatic Adenocarcinoma

EMERALD-3 at ESMO GI 2026: Tremelimumab Plus Durvalumab With or Without Lenvatinib Plus TACE in Embolisation-Eligible HCC

CAPRI-2 GOIM at ESMO GI 2026: Cetuximab Continuation in Molecularly Selected Metastatic Colorectal Cancer

PROACTIF at ESMO GI 2026: Yttrium-90 Radioembolization in HCC With Large Tumors or Portal Vein Thrombosis

Top Trials to Watch at ESMO GI 2026

10 Must-Read Posts In GI Oncology This Week

Insights From FORTITUDE-101 and FORTITUDE-102: FGFR2b Overexpression in Advanced Gastric and GEJ Cancer

Breast-Oncology
Trastuzumab Rezetecan

Trastuzumab Rezetecan Extends Progression-Free Survival in Previously Treated HER2-Positive Metastatic Breast Cancer

Oral SERDs Are Redefining Endocrine Therapy in HR-Positive, HER2-Negative Breast Cancer

Ultra-High TMB May Identify a Rare Immunotherapy-Responsive Subgroup in Metastatic Breast Cancer

Enhertu Becomes the EU’s First Tumor-Agnostic HER2-Directed ADC: What the Approval Means for Solid Tumor Care

T-Bren Shows Early Activity Across HER2-Positive and HER2-Low Advanced Breast Cancer

Can Breast-Conserving Surgery Be Oncologically Safe for Multiple Ipsilateral Breast Cancers?

10 Essential Breast Oncology Posts You Can’t Miss This Week

Lung-Oncology
COVID-19 mRNA

Could COVID-19 mRNA Vaccines Help Prime “Cold” NSCLC for Immunotherapy?

Improving Neoadjuvant and Perioperative Therapy in Resectable NSCLC: Moving Beyond a One-Size-Fits-All Approach

TP53 Gain-of-Function Mutations May Signal Early Osimertinib Resistance in EGFR-Mutant NSCLC

PD-(L)1 Rechallenge in Advanced NSCLC: A Small Signal, but Not a New Standard

Who May Be at Risk of Early Detriment With First-Line Nivolumab Plus Ipilimumab in Metastatic NSCLC?

When ADC Toxicity Is Not the Same for Everyone: A Sex-Based Signal in NSCLC

Nature Medicine Retracts NSCLC Immunochemotherapy Trial: 6 Serious Concerns Explained

OncoDaily TV
1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation? | Dr. Alan Sandler

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

ASCO

OncoDaily Highlights from ASCO 2026 Chicago, USA

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Kefah Mokbel

Kefah Mokbel: Can Diet Influence Cancer Risk and Outcomes?

Empowering Oncologists: How to make the most of your fellowship?

Empowering Oncologists: How to make the most of your fellowship?

STAMP Inhibitors Against CML: Prof. Timothy Hughes

STAMP Inhibitors Against CML: Prof. Timothy Hughes

Oncology's Greatest Threat: A System in Crisis

Oncology’s Greatest Threat: A System in Crisis

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

Not To Miss
SIOP Asia - OncoDaily

20 Posts Not To Miss From SIOP Asia Congress 2026

10 Essential Lung Cancer Posts You Can’t Miss This Week

Oncology Community Welcomes Two New FDA Approvals for Breast Cancer

15 Posts Not To Miss From ASCO Breakthrough 2026

25 Posts Not To Miss from MASCC 2026

EORTC Announces 2027 Summit for Clinical Cancer Research in Brussels

20 Posts Not To Miss From ESMOGynae26

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Burkitt Lymphoma, NHL, EBV, MYC

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): Evolving Biology and Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

CancerWorld

Oncologists
Petros Grivas

Petros Grivas

Oncologists Location Seattle, USA
Dario Trapani

Dario Trapani

Oncologists Location Milan, Italy
Yuman Fong

Yuman Fong

Oncologists Location Duarte, USA
Balu Vijayan

Balu Vijayan

Oncologists Location Kulasekharam, India
C.S. Pramesh

C.S. Pramesh

Oncologists Location Mumbai, India
Dilyara Kaidarova

Dilyara Kaidarova

Oncologists Location Almaty, Kazakhstan
Zulfiquer Otty

Zulfiquer Otty

Oncologists Location Townsville, Australia
Anjaly Mohan

Anjaly Mohan

Oncologists Location Thiruvananthapuram, India

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OncoDaily Medical Journal

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Reviews

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports & Case Series

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports & Case Series